DeepMed Research

University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias

Phase 3

Recruiting

Conditions: Sudden Cardiac Death
Ventricular Fibrillation
Cardiomyopathy
Ventricular Tachycardia

Interventions: Procedure: Cardiac Sympathetic Denervation (CSD)
Drug: Routine Care

First Posted Date: 2009-11-16

Last Posted Date: 2024-01-19

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 40

Registration Number: NCT01013714

Locations: 🇺🇸
UCLA Health, Los Angeles, California, United States
🇺🇸
OHSU, Portland, Oregon, United States
🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

Varenicline vs Placebo for the Treatment of Methamphetamine Dependence

Phase 2

Completed

Conditions: Methamphetamine Dependence
Substance Abuse
Methamphetamine Abuse

Interventions: Drug: Placebo
Drug: Varenicline

First Posted Date: 2009-11-11

Last Posted Date: 2013-03-14

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 20

Registration Number: NCT01011829

Locations: 🇺🇸
UCLA Vine Street Clinic, Los Angeles, California, United States

Evaluating an Emergency Department Observation Syncope Protocol for Older Adults

Not Applicable

Completed

Conditions: Syncope

Interventions: Other: Unstructured, inpatient evaluation
Other: Emergency Department Observation Protocol

First Posted Date: 2009-10-28

Last Posted Date: 2023-02-13

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 123

Registration Number: NCT01003262

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
William Beaumont Hospital, Royal Oaks, Michigan, United States

and more 1 locations

FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease

Not Applicable

Completed

Conditions: Secondary Hyperparathyroidism

Interventions: Other: Placebo
Drug: Sevelamer Carbonate

First Posted Date: 2009-10-21

Last Posted Date: 2023-05-31

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 18

Registration Number: NCT00999037

Locations: 🇺🇸
UCLA, Los Angeles, California, United States

Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration

Phase 2

Conditions: Macular Degeneration

Interventions: Drug: Microplasmin
Drug: Placebo control

First Posted Date: 2009-10-16

Last Posted Date: 2011-09-27

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 30

Registration Number: NCT00996684

Locations: 🇺🇸
Jules Stein Eye Institute/UCLA, Los Angeles, California, United States

Support To Reunite Involve and Value Each Other

Not Applicable

Completed

Conditions: Substance Use
Family Relations
Runaway Behavior
Risky Sexual Behavior

Interventions: Behavioral: STRIVE family intervention

First Posted Date: 2009-10-16

Last Posted Date: 2023-05-15

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 302

Registration Number: NCT00996541

Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)

Phase 3

Active, not recruiting

Conditions: Fetal Alcohol Syndrome
HIV
Nutrition Disorders

Interventions: Behavioral: Philani Intervention Program

First Posted Date: 2009-10-16

Last Posted Date: 2021-10-14

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 1239

Registration Number: NCT00996528

Locations: 🇿🇦
Philani Child Health and Nutrition Project, Khayelitsha, Cape Town, South Africa

Philani Home-based Nutrition Intervention Program

Phase 2

Completed

Conditions: Child Weight

Interventions: Behavioral: Philani nutrition intervention program (mentor mothers)

First Posted Date: 2009-10-15

Last Posted Date: 2009-10-15

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 684

Registration Number: NCT00995592

Locations: 🇿🇦
Philani Child Health and Nutrition Project, Khayelitsha, Cape Town, South Africa
🇿🇦
Philani Child Health and Nutrition Project, Khayelitsha, Cape Town, South Africa

Pilot Trial of Bupropion Versus Placebo for Methamphetamine Abuse in Adolescents

Phase 2

Completed

Conditions: Adolescent Methamphetamine Abuse

Interventions: Drug: Placebo tablets
Drug: Bupropion SR 150mg tabs

First Posted Date: 2009-10-14

Last Posted Date: 2013-04-04

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 19

Registration Number: NCT00994448

Locations: 🇺🇸
Behavioral Health Services- Lincoln Heights Family Recovery Center, Los Angeles, California, United States

Efficacy of Botulinum Toxin Versus Lidocaine in Treating Masticatory Myofascial Face Pain Using Ultrasound and EMG Guided Techniques

Phase 4

Terminated

Conditions: Face Pain

Interventions: Drug: chemodenervation
Drug: lidocaine

First Posted Date: 2009-10-09

Last Posted Date: 2016-12-29

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 17

Registration Number: NCT00992108

Locations: 🇺🇸
Westwood Associates, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy